MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data
Tickers ALNY NEWS RHHBY
Tags Briefs Reiteration Health Care
From Benzinga
Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs
Tickers LLY REGN RHHBY
Tags RHHBY NYSE:LLY,NASDAQ:REGN,OTCMKTS:RHHBY REGN
From InvestorPlace
Why Is European Pharma Giant Argenx Valued At Over $20B Trading Higher On Thursday?
Tickers ARGX JNJ NEWS RHHBY
Tags Health Care JNJ Large Cap
From Benzinga
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
Tickers LZAGF LZAGY NEWS RHHBY
Tags RHHBY Stories That Matter M&A
From Benzinga
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
Tickers BGNE NEWS NVS RHHBY
Tags Health Care Large Cap BGNE
From Benzinga
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
Tickers ASIA ASML AZN GSK
Tags Large Cap Economics SAP
From Benzinga
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
Tickers ABBV BGNE GILD NEWS
Tags General Biotech News
From Benzinga
Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension Challenges
Tickers ALNY NEWS RHHBY
Tags Briefs Reiteration Health Care
From Benzinga
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
Tickers ASML AZN GSK LRLCY
Tags NSRGY RHHBY Market News
From Benzinga
This Drug By Roche And Novartis Reduces Allergic Reactions Across Multiple Foods For People With Food Allergies
Tickers NEWS NVS RHHBY
Tags Benzinga Briefs General
From Benzinga
Move Over Magnificent 7, Say Hello to the GRANOLAS
Tickers AZN GLAXF LRLCY LVMUY
Tags LVMUY SNY ASMLY
From InvestorPlace
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
Tickers NEWS RHHBY SRPT
Tags SRPT Briefs Health Care
From Benzinga
Monte Rosa Therapeutics' AI And Machine Learning Platform Is Adding Significant Value Creation in Cancer Research: Analyst
Tickers GLUE NEWS RHHBY
Tags Equities RHHBY Movers
From Benzinga
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
Tickers HOOK NEWS RHHBY RPTX
Tags RPTX Benzinga why it's moving
From Benzinga
Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal
Tickers GILD HOOK MRK NEWS
Tags General News Biotech
From Benzinga
Roche's One Of Largest Selling Cancer Drug Approved Under The Skin Injection Version In Europe
Tickers HALO RHHBY
Tags Briefs Large Cap Markets
From Benzinga
Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer
Tickers MRK NEWS RHHBY
Tags Benzinga FDA Briefs
From Benzinga
Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference
Tickers AMGN AMZN COR GOOGL
Tags Market News Jim Cramer Stories That Matter
From Benzinga
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
Tickers DXCM RHHBY SRPT
Tags RHHBY DXCM Recent Press Releases
From Motley Fool
Why Is LumiraDx (LMDX) Stock Down 13% Today?
Tickers CLRB HARP LMDX RHHBY
Tags RHHBY NASDAQ:LMDX,OTCMKTS:RHHBY,NASDAQ:CLRB,NASDAQ:HARP LMDX
From InvestorPlace
3 Great Foreign Companies to Invest in Right Now
Tickers ASML RHHBY TEAM
Tags RHHBY ASML TEAM
From Motley Fool
Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M
Tickers LMDX NEWS RHHBF RHHBY
Tags Briefs Health Care M&A
From Benzinga
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
Tickers AZN LLY NVO PFE
Tags RHHBY AZN PFE
From Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
Tickers CALT MCK NVS RHHBY
Tags Expert Ideas Benzinga Small Cap
From Benzinga
This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI. Here's What You Need to Know
Tickers NVDA RHHBY
Tags Recent Press Releases Market News RHHBY
From Motley Fool
Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO
Tickers IPO IPOS NVO RHHBY
Tags Market News IPOs IPO
From Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in December
Tickers INCY KNSA NBIX RHHBY
Tags INCY KNSA NASDAQ:KNSA,OTCMKTS:RHHBY,NASDAQ:NBIX,NASDAQ:INCY
From InvestorPlace
Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial
Tickers PSTX RHHBF RHHBY RHHVF
Tags Briefs PSTX Health Care
From Benzinga
Why Viking Therapeutics Was Crushing It This Week
Tickers NVO RHHBY VKTX
Tags RHHBY VKTX NVO
From Motley Fool
Altimmune’s stock pops as analysts see obesity-drug partnership potential
Tickers ALT AZN LLY NVO
Tags RHHBY AZN PFE
From MarketWatch
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story